Evidence for a protective role of pulmonary surfactant
protein D (SP-D) against influenza A viruses.
It is known that pneumocyte type II (P2) is the main source of phospholipid and protein components of pulmonary surfactant
Processing of pulmonary surfactant
protein B by napsin and cathepsin H.
protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages.
Interaction between pulmonary surfactant
and vernix: a potential mechanism for induction of amniotic fluid turbidity.
Isolation and partial characterization of human low molecular weight protein associated with pulmonary surfactant
was being damaged by smoke and was thus damaging air sacs deep in the lung.
Influence of Pulmonary Surfactant
Protein Mimics on Model Lung Surfactant
Objective: To analyze the therapeutic effect of pulmonary surfactant
(PS) in combination with nasal continuous positive airway pressure (NCPAP) therapy on neonatal respiratory distress syndrome (NRDS).
Windtree's proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant
and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant.
8) demonstrated that both LDL and HDL cholesterols stimulate primary cultures of type II cells to secrete phosphatidylcholine, the major phospholipid component of pulmonary surfactant
M2 EQUITYBITES-January 18, 2013-Discovery Laboratories Inc wins new US patent for pulmonary surfactant
formulations, with expiry in December 2028(C)2013 M2 COMMUNICATIONS http://www.